| 1 |
Mitochondrial uncoupling reveals a novel therapeutic opportunity for p53-defective cancers. Nat Commun. 2018 Sep 26;9(1):3931.
|
| 2 |
Atypical Renal Cysts: A Morphologic, Immunohistochemical, and Molecular Study.Am J Surg Pathol. 2016 Feb;40(2):202-11. doi: 10.1097/PAS.0000000000000557.
|
| 3 |
Inference on germline BAP1 mutations and asbestos exposure from the analysis of familial and sporadic mesothelioma in a high-risk area.Genes Chromosomes Cancer. 2015 Jan;54(1):51-62. doi: 10.1002/gcc.22218. Epub 2014 Sep 18.
|
| 4 |
The expression of cholinesterases in human renal tumours varies according to their histological types.Chem Biol Interact. 2008 Sep 25;175(1-3):340-2. doi: 10.1016/j.cbi.2008.04.003. Epub 2008 Apr 12.
|
| 5 |
Adiponectin gene polymorphisms and obesity increase the susceptibility to arsenic-related renal cell carcinoma.Toxicol Appl Pharmacol. 2018 Jul 1;350:11-20. doi: 10.1016/j.taap.2018.04.034. Epub 2018 Apr 30.
|
| 6 |
Comprehensive analysis of 5-aminolevulinic acid dehydrogenase (ALAD) variants and renal cell carcinoma risk among individuals exposed to lead.PLoS One. 2011;6(7):e20432. doi: 10.1371/journal.pone.0020432. Epub 2011 Jul 20.
|
| 7 |
ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients.Mod Pathol. 2012 Nov;25(11):1516-25. doi: 10.1038/modpathol.2012.107. Epub 2012 Jun 29.
|
| 8 |
[Antisense oligonucleotide targeting survivin induces apoptosis of renal clear-cell carcinoma cells and enhances their sensitivity to epirubicin in vitro]. Zhonghua Zhong Liu Za Zhi. 2005 Aug;27(8):468-70.
|
| 9 |
Spectrum of diverse genomic alterations define non-clear cell renal carcinoma subtypes.Nat Genet. 2015 Jan;47(1):13-21. doi: 10.1038/ng.3146. Epub 2014 Nov 17.
|
| 10 |
PIDDosome expression and the role of caspase-2 activation for chemotherapy-induced apoptosis in RCCs.Cell Oncol. 2010;32(1-2):29-42. doi: 10.3233/CLO-2009-0492.
|
| 11 |
Differential protein profiling in renal-cell carcinoma.Mol Carcinog. 2004 May;40(1):47-61. doi: 10.1002/mc.20015.
|
| 12 |
CUL3 and NRF2 mutations confer an NRF2 activation phenotype in a sporadic form of papillary renal cell carcinoma.Cancer Res. 2013 Apr 1;73(7):2044-51. doi: 10.1158/0008-5472.CAN-12-3227. Epub 2013 Jan 30.
|
| 13 |
Frequent mutations of genes encoding ubiquitin-mediated proteolysis pathway components in clear cell renal cell carcinoma.Nat Genet. 2011 Dec 4;44(1):17-9. doi: 10.1038/ng.1014.
|
| 14 |
GCN2 is a potential prognostic biomarker for human papillary renal cell carcinoma.Cancer Biomark. 2018;22(3):395-403. doi: 10.3233/CBM-170922.
|
| 15 |
Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3.Nat Genet. 2011 Jan;43(1):60-5. doi: 10.1038/ng.723. Epub 2010 Dec 5.
|
| 16 |
Expression and amplification of Topoisomerase-2 in type 1 and type 2 papillary renal cell carcinomas and its correlation with HER2/neu amplification.Pathol Oncol Res. 2011 Sep;17(3):697-703. doi: 10.1007/s12253-011-9372-0. Epub 2011 Apr 2.
|
| 17 |
Prevalence and prognostic value of FBXO11 expression in patients with clear cell renal cell carcinoma.BMC Cancer. 2019 Jun 3;19(1):534. doi: 10.1186/s12885-019-5736-8.
|
| 18 |
In vivo growth of transitional and renal cell carcinoma cell lines can be suppressed by the adenovirus-mediated expression of a soluble form of vascular endothelial growth factor receptor.Oncol Rep. 2006 May;15(5):1333-7.
|
| 19 |
5-Aza-2'-deoxycytidine suppresses human renal carcinoma cell growth in a xenograft model via up-regulation of the connexin 32 gene.Br J Pharmacol. 2008 Apr;153(7):1373-81. doi: 10.1038/bjp.2008.17. Epub 2008 Feb 11.
|
| 20 |
DNA hypermethylation in papillary renal cell carcinoma.BJU Int. 2011 Feb;107(4):664-9. doi: 10.1111/j.1464-410X.2010.09468.x.
|
| 21 |
[Combination therapy with 5-fluorouracil (5-FU), cisplatin (CDDP) and interferon alpha-2B (IFN alpha-2B) for advanced renal cell carcinoma].Gan To Kagaku Ryoho. 1996 Oct;23(12):1689-91.
|
| 22 |
Polymorphisms in the IL-13 and IL-4R genes are associated with the development of renal cell carcinoma.Ann Oncol. 2012 Aug;23(8):2114-2121. doi: 10.1093/annonc/mdr607. Epub 2012 Feb 8.
|
| 23 |
Polymorphism rs4787951 in IL-4R contributes to the increased risk of renal cell carcinoma in a Chinese population.Gene. 2019 Feb 15;685:242-247. doi: 10.1016/j.gene.2018.11.070. Epub 2018 Nov 23.
|
| 24 |
Integrated molecular analysis of clear-cell renal cell carcinoma.Nat Genet. 2013 Aug;45(8):860-7. doi: 10.1038/ng.2699. Epub 2013 Jun 24.
|
| 25 |
iPSC-Derived Embryoid Bodies as Models of c-Met-Mutated Hereditary Papillary Renal Cell Carcinoma.Int J Mol Sci. 2019 Sep 30;20(19):4867. doi: 10.3390/ijms20194867.
|
| 26 |
L1-CAM expression in ccRCC correlates with shorter patients survival times and confers chemoresistance in renal cell carcinoma cells. Carcinogenesis. 2011 Mar;32(3):262-70. doi: 10.1093/carcin/bgq249. Epub 2010 Nov 19.
|
| 27 |
Identification of a yeast artificial chromosome that spans the human papillary renal cell carcinoma-associated t(X;1) breakpoint in Xp11.2.Cancer Genet Cytogenet. 1993 Dec;71(2):164-9. doi: 10.1016/0165-4608(93)90024-g.
|
| 28 |
Modulation of p21-activated kinase 1 alters the behavior of renal cell carcinoma.Int J Cancer. 2007 Nov 1;121(9):1930-1940. doi: 10.1002/ijc.22893.
|
| 29 |
Genetic variants in RKIP are associated with clear cell renal cell carcinoma risk in a Chinese population.PLoS One. 2014 Oct 16;9(10):e109285. doi: 10.1371/journal.pone.0109285. eCollection 2014.
|
| 30 |
Ectopic ACTH syndrome due to Grawitz tumor.Horm Metab Res. 1988 Jul;20(7):453-6. doi: 10.1055/s-2007-1010858.
|
| 31 |
The human tumor antigen PRAME is a dominant repressor of retinoic acid receptor signaling. Cell. 2005 Sep 23;122(6):835-47. doi: 10.1016/j.cell.2005.07.003.
|
| 32 |
Sporadic clear cell renal cell carcinoma but not the papillary type is characterized by severely reduced frequency of primary cilia.Mod Pathol. 2009 Jan;22(1):31-6. doi: 10.1038/modpathol.2008.132. Epub 2008 Jul 25.
|
| 33 |
The coffee diterpene kahweol sensitizes TRAIL-induced apoptosis in renal carcinoma Caki cells through down-regulation of Bcl-2 and c-FLIP.Chem Biol Interact. 2010 Jun 7;186(1):36-42. doi: 10.1016/j.cbi.2010.04.013. Epub 2010 Apr 18.
|
| 34 |
Localization of X chromosome short arm markers relative to synovial sarcoma- and renal adenocarcinoma-associated translocation breakpoints.Hum Genet. 1993 Oct 1;92(3):305-8. doi: 10.1007/BF00244478.
|
| 35 |
Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics (ACMG) and the Clinical Genome Resource (ClinGen). Genet Med. 2020 Feb;22(2):245-257. doi: 10.1038/s41436-019-0686-8. Epub 2019 Nov 6.
|
| 36 |
First-in-Human Phase I Study of the Selective MET Inhibitor, Savolitinib, in Patients with Advanced Solid Tumors: Safety, Pharmacokinetics, and Antitumor Activity.Clin Cancer Res. 2019 Aug 15;25(16):4924-4932. doi: 10.1158/1078-0432.CCR-18-1189. Epub 2019 Apr 5.
|
| 37 |
GSTM1 and GSTT1 polymorphisms contribute to renal cell carcinoma risk: evidence from an updated meta-analysis.Sci Rep. 2015 Dec 14;5:17971. doi: 10.1038/srep17971.
|
| 38 |
Fumaric aciduria: mild phenotype in a 8-year-old girl with novel mutations.J Inherit Metab Dis. 2006 Oct;29(5):683. doi: 10.1007/s10545-006-0321-0. Epub 2006 Aug 5.
|
| 39 |
A Novel Genetic Screen Identifies Modifiers of Age-Dependent Amyloid Toxicity in the Drosophila Brain.Front Aging Neurosci. 2017 Mar 14;9:61. doi: 10.3389/fnagi.2017.00061. eCollection 2017.
|
| 40 |
Methylation of tumour suppressor genes APAF-1 and DAPK-1 and in vitro effects of demethylating agents in bladder and kidney cancer.Br J Cancer. 2006 Dec 18;95(12):1701-7. doi: 10.1038/sj.bjc.6603482. Epub 2006 Nov 28.
|
| 41 |
Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in papillary renal cell carcinoma.Oncogene. 1997 Oct;15(18):2233-9. doi: 10.1038/sj.onc.1201394.
|
| 42 |
BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis. 2009 Apr;30(4):662-70. doi: 10.1093/carcin/bgp042. Epub 2009 Feb 12.
|
| 43 |
Deregulation of E2-EPF ubiquitin carrier protein in papillary renal cell carcinoma.Am J Pathol. 2011 Feb;178(2):853-60. doi: 10.1016/j.ajpath.2010.10.033.
|
| 44 |
Expression of parafibromin in major renal cell tumors.Eur J Histochem. 2012 Oct 23;56(4):e39. doi: 10.4081/ejh.2012.e39.
|
| 45 |
Onconeuronal cerebellar degeneration-related antigen, Cdr2, is strongly expressed in papillary renal cell carcinoma and leads to attenuated hypoxic response.Oncogene. 2009 Sep 17;28(37):3274-85. doi: 10.1038/onc.2009.186. Epub 2009 Jul 6.
|
| 46 |
Cellular retinoic acid binding protein I: expression and functional influence in renal cell carcinoma. Tumour Biol. 2005 Nov-Dec;26(6):313-23. doi: 10.1159/000089262. Epub 2005 Oct 25.
|
| 47 |
Renal cell tumors with clear cell histology and intact VHL and chromosome 3p: a histological review of tumors from the Cancer Genome Atlas database.Mod Pathol. 2017 Nov;30(11):1603-1612. doi: 10.1038/modpathol.2017.72. Epub 2017 Jul 21.
|
| 48 |
Molecular cloning and characterization of FBXO47, a novel gene containing an F-box domain, located in the 17q12 band deleted in papillary renal cell carcinoma.Genes Chromosomes Cancer. 2005 May;43(1):83-94. doi: 10.1002/gcc.20170.
|
| 49 |
Mutations in a novel gene lead to kidney tumors, lung wall defects, and benign tumors of the hair follicle in patients with the Birt-Hogg-Dub syndrome.Cancer Cell. 2002 Aug;2(2):157-64. doi: 10.1016/s1535-6108(02)00104-6.
|
| 50 |
Overexpression of FZD1 is Associated with a Good Prognosis and Resistance of Sunitinib in Clear Cell Renal Cell Carcinoma.J Cancer. 2019 Jan 29;10(5):1237-1251. doi: 10.7150/jca.28662. eCollection 2019.
|
| 51 |
Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody. Cancer Res. 1995 Feb 1;55(3):590-6.
|
| 52 |
SubID, a non-median dichotomization tool for heterogeneous populations, reveals the pan-cancer significance of INPP4B and its regulation by EVI1 in AML.PLoS One. 2018 Feb 7;13(2):e0191510. doi: 10.1371/journal.pone.0191510. eCollection 2018.
|
| 53 |
Renal cell carcinoma with areas mimicking renal angiomyoadenomatous tumor/clear cell papillary renal cell carcinoma.Hum Pathol. 2013 Jul;44(7):1412-20. doi: 10.1016/j.humpath.2012.11.019. Epub 2013 Feb 21.
|
| 54 |
Drug resistance in papillary RCC: from putative mechanisms to clinical practicalities.Nat Rev Urol. 2019 Nov;16(11):655-673. doi: 10.1038/s41585-019-0233-z. Epub 2019 Oct 10.
|
| 55 |
A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature. 2011 Oct 19;480(7375):94-8. doi: 10.1038/nature10539.
|
| 56 |
Applications and limitations of immunohistochemical expression of "Napsin-A" in distinguishing lung adenocarcinoma from adenocarcinomas of other organs.Appl Immunohistochem Mol Morphol. 2013 May;21(3):191-5. doi: 10.1097/PAI.0b013e3182612643.
|
| 57 |
Diagnostic value of cytokeratin 7 and parvalbumin in differentiating chromophobe renal cell carcinoma from renal oncocytoma.Anal Quant Cytol Histol. 2006 Aug;28(4):228-36.
|
| 58 |
PYCR1 is Associated with Papillary Renal Cell Carcinoma Progression.Open Med (Wars). 2019 Aug 14;14:586-592. doi: 10.1515/med-2019-0066. eCollection 2019.
|
| 59 |
Papillary renal cell carcinoma: a clinicopathological and whole-genome exon sequencing study.Int J Clin Exp Pathol. 2015 Jul 1;8(7):8311-35. eCollection 2015.
|
| 60 |
Targeting the nuclear factor-kappaB rescue pathway has promising future in human renal cell carcinoma therapy.Cancer Res. 2007 Dec 15;67(24):11668-76. doi: 10.1158/0008-5472.CAN-07-0632.
|
| 61 |
SETDB2 and RIOX2 are differentially expressed among renal cell tumor subtypes, associating with prognosis and metastization.Epigenetics. 2017;12(12):1057-1064. doi: 10.1080/15592294.2017.1385685. Epub 2018 Jan 22.
|
| 62 |
DNA methylation and histone modifications cause silencing of Wnt antagonist gene in human renal cell carcinoma cell lines.Int J Cancer. 2008 Aug 1;123(3):535-42. doi: 10.1002/ijc.23514.
|
| 63 |
TFE3-associated neurodevelopmental disorder: A distinct recognizable syndrome.Am J Med Genet A. 2020 Mar;182(3):584-590. doi: 10.1002/ajmg.a.61437. Epub 2019 Dec 12.
|
|
|
|
|
|
|
